BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38549200)

  • 1. Stage-Based Detection Methods and Recurrence Patterns for Cutaneous Melanoma.
    Sullivan FG; Adler KB; Boudreaux MD; Hensley LM; Roberts ME; Liles JS; Howard JH
    Am Surg; 2024 Jul; 90(7):1963-1965. PubMed ID: 38549200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
    Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
    Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
    Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
    Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies.
    Rueth NM; Xing Y; Chiang YJ; Cromwell KD; Ross MI; Lee JE; Gershenwald JE; Royal RE; Cormier JN
    Ann Surg; 2014 Jun; 259(6):1215-22. PubMed ID: 24096759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
    Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
    J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance.
    Bleicher J; Swords DS; Mali ME; McGuire L; Pahlkotter MK; Asare EA; Bowles TL; Hyngstrom JR
    J Surg Oncol; 2020 Dec; 122(8):1770-1777. PubMed ID: 33098702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of clinical and instrumental follow-up for cutaneous melanoma.
    Toia F; Cajozzo M; Rosatti F; Di Lorenzo S; Rinaldi G; Mazzucco W; Cordova A
    Surg Oncol; 2022 Sep; 44():101821. PubMed ID: 35947885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.
    Dinnes J; Ferrante di Ruffano L; Takwoingi Y; Cheung ST; Nathan P; Matin RN; Chuchu N; Chan SA; Durack A; Bayliss SE; Gulati A; Patel L; Davenport C; Godfrey K; Subesinghe M; Traill Z; Deeks JJ; Williams HC;
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012806. PubMed ID: 31260100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
    Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
    World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients.
    Park TS; Phan GQ; Yang JC; Kammula U; Hughes MS; Trebska-McGowan K; Morton KE; White DE; Rosenberg SA; Sherry RM
    Ann Surg Oncol; 2017 Apr; 24(4):947-951. PubMed ID: 28144760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse patterns in patients with local and regional cutaneous melanoma.
    Tas F; Erturk K
    Clin Transl Oncol; 2019 Apr; 21(4):412-419. PubMed ID: 30182208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Symptoms Are the Most Frequent Indicators of Recurrence in Patients with American Joint Committee on Cancer Stage II Melanoma.
    Berger AC; Ollila DW; Christopher A; Kairys JC; Mastrangelo MJ; Feeney K; Dabbish N; Leiby B; Frank JA; Stitzenberg KB; Meyers MO
    J Am Coll Surg; 2017 Apr; 224(4):652-659. PubMed ID: 28189663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities.
    Burnett ME; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2021 Mar; 84(3):661-668. PubMed ID: 32763327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
    Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
    Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma.
    Leon-Ferre RA; Kottschade LA; Block MS; McWilliams RR; Dronca RS; Creagan ET; Allred JB; Lowe VJ; Markovic SN
    Melanoma Res; 2017 Aug; 27(4):335-341. PubMed ID: 28296712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
    Moore Dalal K; Zhou Q; Panageas KS; Brady MS; Jaques DP; Coit DG
    Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021: A National Observational Cohort Study of 25 720 Patients With Stage IA to IV Melanoma.
    Helvind NM; Brinch-Møller Weitemeyer M; Chakera AH; Hendel HW; Ellebæk E; Svane IM; Kjærskov MW; Bojesen S; Skyum H; Petersen SK; Bastholt L; Johansen C; Bidstrup PE; Hölmich LR
    JAMA Dermatol; 2023 Nov; 159(11):1213-1222. PubMed ID: 37650576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of surveillance imaging for resected high-risk melanoma.
    Yan MK; Adler NR; Wolfe R; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ
    Asia Pac J Clin Oncol; 2023 Aug; 19(4):566-573. PubMed ID: 36540019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Descriptive analysis of cutaneous recurrence patterns in patients with melanoma].
    Marcoval J; Ferreres JR; Penín RM; Piulats JM; Caminal JM; Fabra A
    Actas Dermosifiliogr; 2011 Dec; 102(10):791-6. PubMed ID: 21658662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.